載入...
ISTH DIC subcommittee communication on anticoagulation in COVID‐19
Hypercoagulability is an increasingly recognized complication of SARS‐CoV‐2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID‐19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special...
Na minha lista:
| 發表在: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7404846/ https://ncbi.nlm.nih.gov/pubmed/32881336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15004 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|